The “PROMIS” of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis?

2018 ◽  
Vol 73 (1) ◽  
pp. 31-32 ◽  
Author(s):  
Jochen Walz
2018 ◽  
Vol 73 (6) ◽  
pp. e151-e152
Author(s):  
Rita Faria ◽  
Marta O. Soares ◽  
Eldon Spackman ◽  
Hashim U. Ahmed ◽  
Louise C. Brown ◽  
...  

2020 ◽  
Vol 3 (1) ◽  
pp. 32-41 ◽  
Author(s):  
Ivo G. Schoots ◽  
Anwar R. Padhani ◽  
Olivier Rouvière ◽  
Jelle O. Barentsz ◽  
Jonathan Richenberg

Medicine ◽  
2019 ◽  
Vol 98 (29) ◽  
pp. e16326 ◽  
Author(s):  
Fuxiang Liang ◽  
Meixuan Li ◽  
Liang Yao ◽  
Xiaoqin Wang ◽  
Jieting Liu ◽  
...  

2020 ◽  
Vol 78 (3) ◽  
pp. 307-309
Author(s):  
Anwar R. Padhani ◽  
Geert Villeirs ◽  
Hashim U. Ahmed ◽  
Valeria Panebianco ◽  
Ivo G. Schoots ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-17
Author(s):  
Rachid Sammouda ◽  
Abdu Gumaei ◽  
Ali El-Zaart

Prostate Cancer (PCa) is one of the common cancers among men in the world. About 16.67% of men will be affected by PCa in their life. Due to the integration of magnetic resonance imaging in the current clinical procedure for detecting prostate cancer and the apparent success of imaging techniques in the estimation of PCa volume in the gland, we provide a more detailed review of methodologies that use specific parameters for prostate tissue representation. After collecting over 200 researches on image-based systems for diagnosing prostate cancer, in this paper, we provide a detailed review of existing computer-aided diagnosis (CAD) methods and approaches to identify prostate cancer from images generated using Near-Infrared (NIR), Mid-Infrared (MIR), and Magnetic Resonance Imaging (MRI) techniques. Furthermore, we introduce two research methodologies to build intelligent CAD systems. The first methodology applies a fuzzy integral method to maintain the diversity and capacity of different classifiers aggregation to detect PCa tumor from NIR and MIR images. The second methodology investigates a typical workflow for developing an automated prostate cancer diagnosis using MRI images. Essentially, CAD development remains a helpful tool of radiology for diagnosing prostate cancer disease. Nonetheless, a complete implementation of effective and intelligent methods is still required for the PCa-diagnostic system. While some CAD applications work well, some limitations need to be solved for automated clinical PCa diagnostic. It is anticipated that more advances should be made in computational image analysis and computer-assisted approaches to satisfy clinical needs shortly in the coming years.


Sign in / Sign up

Export Citation Format

Share Document